Garmin unveils Varia RearVue 820, its brightest and most powerful radar tail light for cyclists — Neutral
GRMN PRNewsWire — February 03, 2026With advanced vehicle tracking, superior battery life and a brighter tail light than ever before, cyclists can ride with greater peace of mind OLATHE, Kan., Feb. 3, 2026 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced Varia™ RearVue 820 , its most innovative radar tail light that can help cyclists be more aware and visible while riding on the road.
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration — Neutral
IVVD GlobeNewsWire — February 03, 2026NEW HAVEN, Conn., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced it has received and is aligned with advice from the U.S. Food and Drug Administration (FDA) on the LIBERTY Phase 3 clinical trial, which will assess the safety and immunologic profile of VYD2311, the company's vaccine- alternative monoclonal antibody investigational candidate for the prevention of COVID-19, versus commercially available mRNA COVID vaccines. The trial will also explore the safety and immunologic profile of VYD2311 and mRNA COVID vaccine administered simultaneously.
BellRing Brands Announces Leadership Transition Plan — Neutral
BRBR GlobeNewsWire — February 03, 2026ST. LOUIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (the “Company”) today announced that its President and Chief Executive Officer Darcy Davenport has decided to retire from the Company, effective upon the earlier of the appointment of a new Chief Executive Officer or September 30, 2026, the end of the Company's fiscal year. Ms. Davenport will continue to serve as President and Chief Executive Officer and as a member of the Board until the effective date of the transition, after which she will serve in an advisory role to ensure a smooth transition of leadership responsibilities and …
Artificial intelligence model ChatGPT has outlined a bullish case scenario for Tesla (NASDAQ: TSLA) shares in 2026.
Best Growth Stocks to Buy for February 3rd — Positive
SDVKY TCBI WDC Zacks Investment Research — February 03, 2026SDVKY, WDC and TCBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 3, 2026.
In Google earnings, analysts want answers on Apple's Siri-Gemini deal — Neutral
AAPL GOOG GOOGL CNBC — February 03, 2026Analysts say they're looking for details on the deal between Apple and Google to revamp the iPhone maker's AI products, including Siri. The deal is one of the most prominent yet for Gemini, and the scale of Apple's user base — 2.5 billion active devices — is important for Google, even without specific user data, analysts said.
Amazon is ratcheting up fast delivery and raising the stakes for rivals like Walmart — Positive
AMZN WMT Business Insider — February 03, 2026Amazon sets a new delivery speed record in 2025, with over 13 billion same- or next-day deliveries worldwide. Prime members in the US received a 30% increase in fast deliveries in 2025, the company said.
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium — Neutral
PLSE Business Wire — February 03, 2026HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced its nPulse technology will be featured in a late-breaking science session and a live case transmission featuring the nPulse Cardiac Catheter integrated with Abbott's EnSiteX™ 3D Mapping System at the 31st Annual AF Symposium 2026 meeting, being held February 5-7 in Bo.
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer — Neutral
RLAY GlobeNewsWire — February 03, 2026Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of zovegalisib in combination with fulvestrant Initial Phase 1/2 data of zovegalisib + fulvestrant at the 400mg BID fed (Phase 3 dose) in CDK4/6-experienced patients to be presented at ESMO Targeted Anticancer Therapies Congress on March 16 CAMBRIDGE, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough …
J & J Snack Foods Reports Fiscal 2026 First Quarter Results — Neutral
JJSF GlobeNewsWire — February 03, 2026MOUNT LAUREL, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) today reported financial results for the first quarter ended December 27, 2025.
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit — Neutral
FHTX GlobeNewsWire — February 03, 2026WATERTOWN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Guggenheim Emerging Outlook: Biotech Summit, being held February 11-12, 2026, in New York, NY.
Electra Awards $6.1 Million Contract to EXP Services for Project Management and Engineering Support at Ontario Refinery — Neutral
ELBM GlobeNewsWire — February 03, 2026TORONTO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) has awarded a US$6.1 million (C$8.3 million) contract to EXP Services Inc. ("EXP") to provide engineering, project management, and construction management services during the construction phase of Electra's Ontario battery materials refinery project.
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing — Neutral
ANL GlobeNewsWire — February 03, 2026SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd.
X4 Pharmaceuticals to Participate in Guggenheim's Emerging Outlook: Biotech Summit 2026 — Neutral
XFOR GlobeNewsWire — February 03, 2026BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today announced that the management team will participate in the upcoming Guggenheim Emerging Outlook: Biotech Summit on February 11-12, 2026 in New York. The X4 team will hold a fireside chat on February 12th at 12:30 p.m.
BellRing Brands Reports Results for the First Quarter of Fiscal Year 2026; Narrows Fiscal Year 2026 Outlook — Neutral
BRBR GlobeNewsWire — February 03, 2026ST. LOUIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the first fiscal quarter ended December 31, 2025.
HP Inc. to Announce First Quarter Fiscal 2026 Earnings on Feb 24, 2026 — Neutral
HPQ GlobeNewsWire — February 03, 2026PALO ALTO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the first fiscal quarter ended January 31, 2026 on Tuesday, Feb 24, 2026 at 5:00 p.m. ET / 2:00 p.m. PT.
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced — Neutral
TLRY GlobeNewsWire — February 03, 2026Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery
Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results — Neutral
OFIX Business Wire — February 03, 2026LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2025 financial results on Tuesday, February 24, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other location.
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline — Neutral
BCYC Business Wire — February 03, 2026CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced leadership transitions for its next phase of innovation. Travis Thompson, who began at Bicycle in April 2018 and most recently served as Bicycle's senior vice president and chief accounting officer and previously spent his career at EY in its life.